$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] The xenobiotic inhibitor profile of cytochrome P4502C8 원문보기

British journal of clinical pharmacology, v.50 no.6, 2000년, pp.573 - 580  

Ong, Chin‐Eng ,  Coulter, Sally ,  Birkett, Donald J. ,  Bhasker, C. Ramana ,  Miners, John O.

Abstract AI-Helper 아이콘AI-Helper

Aims To investigate inhibition of recombinant CYP2C8 by: (i) prototypic CYP isoform selective inhibitors (ii) imidazole/triazole antifungal agents (known inhibitors of CYP), and (iii) certain CYP3A substrates (given the apparent overlapping substrate specificity of CYP2C8 and CYP3A).Methods CYP2C8...

참고문헌 (39)

  1. Miners, John O., Birkett, Donald J.. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. British journal of clinical pharmacology, vol.45, no.6, 525-538.

  2. Bertilsson, Leif. Geographical/Interracial Differences in Polymorphic Drug Oxidation : Current State of Knowledge of Cytochromes P450 (CYP) 2D6 and 2C19. Clinical pharmacokinetics, vol.29, no.3, 192-209.

  3. Coller, J. K., Somogyi, A. A., Bochner, F.. Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4. Xenobiotica, vol.29, no.10, 973-986.

  4. Xu, Zhen‐Hua, Wang, Wei, Zhao, Xue‐Jun, Huang, Song‐Lin, Zhu, Bing, He, Nan, Shu, Yan, Liu, Zhao‐Qian, Zhou, Hong‐Hao. Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N‐demethylation of sertraline in human liver microsomes. British journal of clinical pharmacology, vol.48, no.3, 416-423.

  5. Baldwin,, Clarke,, Chenery,. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone. British journal of clinical pharmacology, vol.48, no.3, 424-432.

  6. M??ck, Wolfgang. Rational Assessment of the Interaction Profile of Cerivastatin Supports its Low Propensity for Drug Interactions :. Drugs, vol.56, no.suppl1, 15-23.

  7. Cancer Res Rahman A 5543 54 1994 Selective biotransformation of taxol to 6α‐hydroxytaxol by human cytochrome P4502C8 

  8. Drug Metab Dispos Yamazaki H 1260 27 1999 Oxidation of troglitazone to a quinone‐type metabolite catalyzed by cytochrome P450 2C8 and P450 3A4 in human liver microsomes 

  9. Drug Metab Dispos Becquemont L 1068 27 1999 Cytochrome P450 3A4 and 2C8 are involved in zopiclone metabolism 

  10. Kerr, B.M., Thummel, K.E., Wurden, C.J., Klein, S.M., Kroetz, D.L., Gonzalez, F.J., Levy, R.. Human liver carbamazepine metabolism - Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochemical pharmacology, vol.47, no.11, 1969-1979.

  11. J Pharmacol Exp Ther Sonnichsen DS 566 275 1995 Variability in human cytochrome P450 paclitaxel metabolism 

  12. Tracy, Timothy S., Korzekwa, Kenneth R., Gonzalez, Frank J., Wainer, Irving W.. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. British journal of clinical pharmacology, vol.47, no.5, 545-552.

  13. Nadin, Louise, Murray, Michael. Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes. Biochemical pharmacology, vol.58, no.7, 1201-1208.

  14. Rifkind, Arleen B., Lee, Charis, Chang, Thomas K.H., Waxman, David J.. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: Regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Archives of biochemistry and biophysics, vol.320, no.2, 380-389.

  15. ISSX Proc Rees HC 72 14 1999 A novel genetic polymorphism in the cytochrome P450 CYP2C8 

  16. 10.1016/S0065-7743(08)60744-7 

  17. ONG, C. E., MINERS, J. O., BIRKETT, D. J., BHASKER*, C. R.. Baculovirus-mediated expression of cytochrome P4502C8 and human NADPH-cytochrome P450 reductase : optimization of protein expression. Xenobiotica, vol.28, no.2, 137-152.

  18. J Pharmacol Exp Ther Miners JO 1076 272 1995 Human hepatic cytochrome P450 2C9 catalyzes the rate‐limiting pathway of torsemide metabolism 

  19. Miners, John O., Coulter, Sally, Birkett, Donald J., Goldstein, Joyce A.. Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes :. Pharmacogenetics, vol.10, no.3, 267-270.

  20. Chang, T.K.H., Gonzalez, F.J., Waxman, D.J.. Evaluation of Triacetyloleandomycin, α-Nasymphthoflavone and Diethyldithiocarbamate as Selective Chemical Probes for Inhibition of Human Cytochromes P450. Archives of biochemistry and biophysics, vol.311, no.2, 437-442.

  21. Xenobiotica Ono S 681 26 1996 10.3109/00498259609046742 Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA‐expressed human P450s and human liver microsomes 

  22. Cancer Res Harris JW 4026 54 1994 Metabolism of taxol by human hepatic microsomes and liver slices: Participation of cytochrome P450 3A4 and an unknown P450 enzyme 

  23. Back, DJ, Tjia, JF. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.. British journal of clinical pharmacology, vol.32, no.5, 624-626.

  24. ISSX Proc Gibbs MA 157 12 1997 Differential inhibition of CYP3A4 and CYP3A5 by antifungal agents 

  25. Murray, Michael. Mechanisms of the Inhibition of Cytochrome P 450-Mediated Drug Oxidation by Therapeutic Agents. Drug metabolism reviews, vol.18, no.1, 55-81.

  26. Back, DJ, Tjia, JF, Karbwang, J, Colbert, J. In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.. British journal of clinical pharmacology, vol.26, no.1, 23-29.

  27. MAURICE, Manuelle, EMILIANI, Stephane, DALET‐BELUCHE, Isabelle, DERANCOURT, Jean, LANGE, Reinhard. Isolation and characterization of a cytochrome P450 of the IIA subfamily from human liver microsomes. European journal of biochemistry, vol.200, no.2, 511-517.

  28. TASSANEEYAKUL, W., *, D. J. BIRKETT and J. O. MINERS. Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and nonsteroidal anti-inflammatory agents. Xenobiotica, vol.28, no.3, 293-301.

  29. Mol Pharmacol Kronbach T 89 36 1989 Oxidation of midazolam and triazolam by by human liver cytochrome P450 IIIA4 

  30. Zhang, H., Coville, P. F., Walker, R. J., Miners, J. O., Birkett, D. J., Wanwimolruk, S.. Evidence for involvement of human CYP3A in the 3‐hydroxylation of quinine. British journal of clinical pharmacology, vol.43, no.3, 245-252.

  31. Drug Metab Dispos Rodrigues AD 765 23 1995 In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH‐P450 reductase: comparison to human liver microsomes and precision cut tissue slices 

  32. J Pharmacol Exp Ther Von Moltke LL 370 276 1996 Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of predicted interaction with ketoconazole 

  33. Drug Metab Dispos Fabre G 978 21 1993 Evidence of CYP3A4 mediated N‐deethylation of amiodarone in human liver microsomal fractions 

  34. Ghahramani, P., Ellis, S. W., Lennard, M. S., Ramsay, L. E., Tucker, G. T.. Cytochromes P450 mediating the N‐demethylation of amitriptyline. British journal of clinical pharmacology, vol.43, no.2, 137-144.

  35. Drug Metab Dispos Jonsson G 137 23 1995 Budesonide is metabolised by cytochrome P450, 3A (CYP3A) enzymes in human liver. 

  36. Transplant Proc Maurer G 19 17 1 1985 Metabolism of cyclosporin 

  37. Andersson, T, Miners, JO, Veronese, ME, Birkett, DJ. Diazepam metabolism by human liver microsomes is mediated by both S‐ mephenytoin hydroxylase and CYP3A isoforms.. British journal of clinical pharmacology, vol.38, no.2, 131-137.

  38. Drug Metab Dispos Pichard L 711 18 1990 Identification of the rabbit and human cytochromes P450 IIIA as the major enzymes involved in the N‐demethylation of diltiazem 

  39. Bargetzi, Mario J, Aoyama, Toshifumi, Gonzalez, Frank J, Meyer, Urs A. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clinical pharmacology and therapeutics, vol.46, no.5, 521-527.

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로